Attorneys

Attorneys

Frances M. Jagla

Shareholder | Seattle | 206.223.7749 | jaglaf@lanepowell.com

Areas of Practice

Fran Jagla focuses her practice on trademark, copyright, Internet domain name matters and unfair competition counseling. She has extensive U.S. and international experience in name development, clearance filing, registration, maintenance and enforcement of trademarks and copyrights for Fortune 100 companies. Fran possesses in-depth knowledge of trademark-related acquisitions, divestitures, licensing, Internet domain name matters and regulatory issues relating to healthcare trademarks.

Professional Experience

  • Leydig, Voit & Mayer Ltd., Counsel (2008-2012)
  • Law Office of Frances M. Jagla, PLLC (2007-2008)
  • Microsoft Corporation, Senior Attorney – Trademarks (2004-2007)
  • Abbott Laboratories, Senior Counsel (1989-2004)
  • Miles, Inc., Attorney (1984-1989)

Admitted to Practice

  • Washington
  • U.S. District Court, Western District of Washington
  • U.S. District Court, Northern District of Indiana
  • Illinois (inactive)
  • Indiana (inactive)

Academics and Accreditations

  • Valparaiso University School of Law (J.D., 1984)
  • Indiana University (B.A., Political Science, 1981)
  • Legal Lean Sigma® and Project Management — Yellow Belt Certification

Practice Group and Specialty Team Memberships

  • Canada Practice
  • Food, Beverage and Hospitality
  • Intellectual Property and Technology
  • Startups and Emerging Companies

Representative Matters and Clients

  • Acquisition of Knoll AG
  • Spin-off of Abbott Laboratories’ Hospital Products Division into Hospira
  • Divestiture of Abbott Laboratories Animal Health and Agriculture Divisions
  • Negotiations with the United States Adopted Names Council and the World Health Organization for adoption of preferred non-proprietary names (USAN and INN)
  • Negotiations with FDA and EMEA for approval of preferred trademarks for pharmaceutical products

Publications

  • “Naming the Product:  The Intersection of the FDA and Trademark Law,” IP Litigator, Co-author (January/February 2009)
  • “Impact of Madrid Protocol on U.S. Practitioners:  An In-House Perspective,” International Trademark Association publication, Co-author (2003)

Speaking Engagements

  • “Using Madrid Protocol — Risks and Rewards,” International Trademark Association’s 136th Annual Meeting, Panelist (May 13, 2014)
  • “Trademark Year in Review,” Washington State Bar Association’s 19th Annual Intellectual Property Institute (March 21, 2014)
  • “Trademarks in Regulated Industries, Such as Alcohol, Tobacco, Pharmaceuticals and Eco Marks,” International Trademark Association’s Roundtable Discussion, Moderator (April 18, 2013)
  • “Plugging the Leaky Pipeline: Promoting Women’s Leadership in Our Legal Community,” Washington Women Lawyer’s Town Hall Discussion, Panelist (February 27, 2013)
  • “The Role of the Attorney in the Use of the Madrid System in the United States,” Instituto Mexicano de la Propiedad Industrial Seminar (February 19, 2013)
  • “The Madrid Protocol and the Community Trademark,” International Trademark Association Roundtable (October 24, 2012)
  • “gTLDs:  Status, Process and How is It Working?” International Trademark Association Roundtable Discussion (April 10, 2012)
  • “Building the Bridge Between Legal and Marketing,” International Trademark Association’s 2010 Annual Meeting, Moderator (May 25, 2010)
  • “Policing Trademarks on the Internet and Web 2.0,” International Trademark Association Roundtable (January 19, 2010)
  • “Trademarks and the Internet — Three Things You Should Know,” Center for American and International Law Annual IP Meeting (November 10-11, 2008)
  • “FDA Bootcamp-Naming the Product:  The Intersection of FDA and Trademark Law,” American Intellectual Property Law Association Annual Meeting (October 23-25, 2008)
  • “The Future of Pharmaceutical Trademarks,” Pharmaceutical Trade Marks Group Autumn Meeting (October 1-4, 2008)
  • “Strategies for the International Protection of Intellectual Property,” Inside Counsel Super Conference (2007)
  • “Adherence to Madrid Protocol and Protection for Famous Names,” USPTO/ASEAN Trademark Office Officials Meeting/Bangkok (2006)
  • “International Trademark Enforcement and Filing Strategies,” International Trademark Association’s Meeting China Trademark Owners (2005)
  • “United States Food and Drug Administration and European EMEA — Pharmaceutical Trademarks,” Pharmaceutical Trade Marks Group Annual Meeting (2004)

Awards and Honors

  • Named a “Leading Trademark Professional” by World Trademark Review 1000 (2014)
  • Paul A. Welter 1st Annual Award for Excellence in Trademark Law, Merchant & Gould/William Mitchell School of Law (2007)
  • Microsoft Corporate Marketing Group’s Most Valued Partner (2006-2007)

Professional and Community Activities

  • Board of Trustees, MedERRS, Institute for Safe Medication Practices (2005-Present)
  • International Trademark Association (“INTA”)
    • Co-chair, Government Officials and Education Training Committee, Office of Harmonization in the Internal Market’s Industry Training Seminars Subcommittee (2014-2015)
    •  Bulletins Committee (2010-Present)
    •     Board of Directors (2005-2007)
    •     Subcommittee Chair, Madrid Protocol (2004)
    •     Board of Directors, Executive Committee, Secretary (1995-1997)
    •     Annual Meeting Chair (1997)
  • Pharmaceutical Trade Marks Group (“PTMG”)
    •     Board of Directors (2004)
  • Member, Washington State Bar Association
  • Member, Indiana University Alumni Association